Purchases and Sales Made in Q4 2022 in Xortx Therapeutics Inc. (XRTX)
This table provides information about the institutional ownership of Xortx Therapeutics Inc. (XRTX) during Q4 2022. The information is specifically focused on institutions that hold shares of XORTX Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
1.49MNew |
$1.09M - $16M
|
1.49M
$1.33M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
17.6KNew |
$12.9K - $189K
|
17.6K
$15.7K
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
363+ 471.43% |
$265 - $3.89K
|
440
$392
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
66New |
$48.2 - $707
|
66
$58.7
|
|
|
Feb 13, 2023
Q4 2022
|
Cibc World Market Inc.
Toronto, A6 |
BUY
|
- |
4+ 0.02% |
$2.92 - $42.8
|
19K
$16.9K
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-223- 99.11% |
$163 - $2.39K
|
2
$1.78
|